Return to Today's science sparks archives

2019-07-01

Fig 2. Response of patients with epithelial ovarian cancer by germline BRCA mutation status

Fig 2. Response of patients with epithelial ovarian cancer by germline BRCA mutation status
  • Konstantinopoulos PA, Barry WT, Birrer M, Westin SN, Cadoo KA, Shapiro GI, Mayer EL, O'Cearbhaill RE, Coleman RL, Kochupurakkal B, Whalen C, Curtis J, Farooq S, Luo W, Eismann J, Buss MK, Aghajanian C, Mills GB, Palakurthi S, Kirschmeier P, Liu J, Cantley LC, Kaufmann SH, Swisher EM, D'Andrea AD, Winer E, Wulf GM, Matulonis UA

  • Lancet Oncol. 2019 Apr;20(4):570-580.

2019-07-02

Fig. 1. Identification of an additional protein–DNA interface in the crystal structure of the SRY.h-cGASCD–DNA complex.

Fig. 1. Identification of an additional protein–DNA interface in the crystal structure of the SRY.h-cGASCD–DNA complex.
  • Xie W, Lama L, Adura C, Tomita D, Glickman JF, Tuschl T, Patel DJ

  • Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11946-11955.

2019-07-03

Fig 1. Schematic outlining key findings from the work of Zhou and colleagues.

Fig 1. Schematic outlining key findings from the work of Zhou and colleagues.
  • Shoushtari AN

  • Clin Cancer Res. 2019 Jun 15;25(12):3473-3475.

2019-07-05

Fig. 4. Endoderm repolarization: the different ways cells can re-polarize.

Fig. 4. Endoderm repolarization: the different ways cells can re-polarize.
  • Nowotschin S, Hadjantonakis AK, Campbell K

  • Development. 2019 Jun 3;146(11).
Open Access button

2019-07-08

Central Illustration. Core Components Necessary for Preparing the Cardio-Oncology Workforce

Central Illustration. Core Components Necessary for Preparing the Cardio-Oncology Workforce
  • Hayek SS, Ganatra S, Lenneman C, Scherrer-Crosbie M, Leja M, Lenihan DJ, Yang E, Ryan TD, Liu J, Carver J, Mousavi N, O'Quinn R, Arnold A, Banchs J, Barac A, Ky B

  • J Am Coll Cardiol. 2019 May 7;73(17):2226-2235.

2019-07-09

Fig. 2. The a) preoperative and b) postoperative T2W midsagittal MRI images showing the VUJ, PMU and ARJ anatomical landmarks.

Fig. 2. The a) preoperative and b) postoperative T2W midsagittal MRI images showing the VUJ, PMU and ARJ anatomical landmarks.
  • Ha HK, Luiting HB, Graham PL, Patel MI, Sandhu JS, Akin O, Mungovan SF

  • BMC Urol. 2019 Jun 18;19(1):54.
Open Access button

2019-07-10

Fig 1. Targeted Sequencing in MyM Patients.

Fig 1. Targeted Sequencing in MyM Patients.
  • Epstein-Peterson ZD, Devlin SM, Stein EM, Klimek VM, Saltz LB, Tallman MS

  • Leuk Res. 2019 Jul;82:19-23.

2019-07-11

Fig 1. ATM deficiency impairs CSR in vitro.

Fig 1. ATM deficiency impairs CSR in vitro.
  • Nicolas L, Cols M, Smolkin R, Fernandez KC, Yewdell WT, Yen WF, Zha S, Vuong BQ, Chaudhuri J

  • J Immunol. 2019 Jun 1;202(11):3137-3142.

2019-07-12

Figure 2. Interaction between the B‐cell receptor (BCR) signaling and the Toll‐like receptor (TLR) signaling pathways.

Figure 2. Interaction between the B‐cell receptor (BCR) signaling and the Toll‐like receptor (TLR) signaling pathways.
  • Younes A

  • Hematol Oncol. 2019 Jun;37 Suppl 1:105-109.

2019-07-15

Fig. 3. Evaluation of macrophage chemoattractant and proliferation in the irreversible electroporation (IRE)-treated ureter.

Fig. 3. Evaluation of macrophage chemoattractant and proliferation in the irreversible electroporation (IRE)-treated ureter.
  • Ueshima E, Fujimori M, Kodama H, Felsen D, Chen J, Durack JC, Solomon SB, Coleman JA, Srimathveeravalli G

  • Am J Physiol Renal Physiol. 2019 Jul 1;317(7):F52-F64.

2019-07-17

Fig 1. Schematic design principle of FRNPs.

Fig 1. Schematic design principle of FRNPs.
  • Pal S, Ray A, Andreou C, Zhou Y, Rakshit T, Wlodarczyk M, Maeda M, Toledo-Crow R, Berisha N, Yang J, Hsu HT, Oseledchyk A, Mondal J, Zou S, Kircher MF

  • Nat Commun. 2019 Apr 26;10(1):1926.
Open Access button

2019-07-18

Figure 4. Bioinformatics Analyses of Illumina HT Sequencing Data from LIGS Libraries.

Figure 4. Bioinformatics Analyses of Illumina HT Sequencing Data from LIGS Libraries.
  • Zumrut HE, Batool S, Argyropoulos KV, Williams N, Azad R, Mallikaratchy PR

  • Mol Ther Nucleic Acids. 2019 Jun 4;17:150-163.
Open Access button

2019-07-19

Fig. 4. 70-year-old man with primary cSCC in scalp underwent staging.

Fig. 4. 70-year-old man with primary cSCC in scalp underwent staging.
  • Mahajan S, Barker CA, Singh B, Pandit-Taskar N

  • Nucl Med Commun. 2019 Jul;40(7):744-751.

2019-07-22

Fig 1A. Menin-Independent Activity of MI-2 in Glioma.

Fig 1A. Menin-Independent Activity of MI-2 in Glioma.
  • Phillips RE, Yang Y, Smith RC, Thompson BM, Yamasaki T, Soto-Feliciano YM, Funato K, Liang Y, Garcia-Bermudez J, Wang X, Garcia BA, Yamasaki K, McDonald JG, Birsoy K, Tabar V, Allis CD

  • Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7957-7962.

2019-07-23

Fig 1. Theoretical diagram of context‐based image retrieval.

Fig 1. Theoretical diagram of context‐based image retrieval.
  • Rotemberg V, Halpern A

  • Br J Dermatol. 2019 Jul;181(1):5-6.
Open Access button

2019-07-24

Potential units that are adequately dosed for a 70-kg patient.

Potential units that are adequately dosed for a 70-kg patient.
  • Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, Politikos I, Shpall EJ, Scaradavou A, Dehn J

  • Blood Adv. 2019 Apr 23;3(8):1267-1271.
Open Access button

2019-07-25

Fig 3. Absence of BRCA-driven HRD in MM.

Fig 3. Absence of BRCA-driven HRD in MM.
  • Maura F, Degasperi A, Nadeu F, Leongamornlert D, Davies H, Moore L, Royo R, Ziccheddu B, Puente XS, Avet-Loiseau H, Cambell PJ, Nik-Zainal S, Campo E, Munshi N, Bolli N

  • Nat Commun. 2019 Jul 5;10(1):2969.

2019-07-26

FIG 4. Sublineages coexist after rapid diversification, in which the pbp5 mutation becomes fixed in the total intestinal VRE population.

FIG 4. Sublineages coexist after rapid diversification, in which the pbp5 mutation becomes fixed in the total intestinal VRE population.
  • Dubin KA, Mathur D, McKenney PT, Taylor BP, Littmann ER, Peled JU, van den Brink MRM, Taur Y, Pamer EG, Xavier JB

  • Infect Immun. 2019 Jun 20;87(7). pii: e00102-19.
Open Access button

2019-07-29

Fig 2. Spectrum of adult and pediatric tumors harboring NTRK gene fusions. GIST, gastrointestinal stromal tumor.

Fig 2. Spectrum of adult and pediatric tumors harboring NTRK gene fusions. GIST, gastrointestinal stromal tumor.
  • Hsiao SJ, Zehir A, Sireci AN, Aisner DL

  • J Mol Diagn. 2019 Jul;21(4):553-571.
Open Access button

2019-07-30

Graphical Abstract

Graphical Abstract
  • Li J, Dong A, Saydaminova K, Chang H, Wang G, Ochiai H, Yamamoto T, Pertsinidis A

  • Cell. 2019 Jul 11;178(2):491-506.e28.

2019-07-31

Figure 1. Three-Dimensional Imaging Approach Provides Accurate Tissue Volume and Cell Localization

Figure 1. Three-Dimensional Imaging Approach Provides Accurate Tissue Volume and Cell Localization
  • Fu YY, Egorova A, Sobieski C, Kuttiyara J, Calafiore M, Takashima S, Clevers H, Hanash AM

  • Immunity. 2019 Jul 16;51(1):90-103.e3.

2019-08-01

Fig 1. Trp53R172H leads to accelerated onset of hematologic malignancies.

Fig 1. Trp53R172H leads to accelerated onset of hematologic malignancies.
  • Loizou E, Banito A, Livshits G, Ho YJ, Koche RP, Sánchez-Rivera FJ, Mayle A, Chen CC, Kinalis S, Bagger FO, Kastenhuber ER, Durham BH, Lowe SW

  • Cancer Discov. 2019 Jul;9(7):962-979.

2019-08-02

Central Illustration.

Central Illustration.
  • Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J, Zeiher A, Jaiswal S, Schulz C, Blankstein R, Bolton KL, Steensma D, Levine RL, Ebert BL

  • J Am Coll Cardiol. 2019 Jul 30;74(4):567-577.

2019-08-05

Fig 1. (A) T1-weighted post-contrast MRI showing VS (white arrow) at pretreatment baseline (left panel) and after 32 months on treatment with BEV (right panel).

Fig 1. (A) T1-weighted post-contrast MRI showing VS (white arrow) at pretreatment baseline (left panel) and after 32 months on treatment with BEV (right panel).
  • Karajannis MA, Hagiwara M, Schreyer M, Haque S

  • Neuro Oncol. 2019 Jun 10;21(6):822-824.

2019-08-06

Fig 1. Treatment Algorithm 1: First-line treatment for R/M HNSCC patients. Immunotherapy treatment algorithm for R/M Systemic Therapy Naïve HNSCC.

Fig 1. Treatment Algorithm 1: First-line treatment for R/M HNSCC patients. Immunotherapy treatment algorithm for R/M Systemic Therapy Naïve HNSCC.
  • Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL

  • J Immunother Cancer. 2019 Jul 15;7(1):184.
Open Access button

2019-08-07

Fig 2. Pelvic MRI at 10 weeks gestation.

Fig 2. Pelvic MRI at 10 weeks gestation.
  • Ramirez PT, Abu-Rustum NR, Euscher E

  • Int J Gynecol Cancer. 2019 Jan 23. pii: ijgc-2018-000187.
Open Access button

2019-08-08

MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation.

MsTtfA/MtbTtfA is required for mycobacterial growth and cell elongation.
  • Fay A, Czudnochowski N, Rock JM, Johnson JR, Krogan NJ, Rosenberg O, Glickman MS

  • MBio. 2019 Jun 25;10(3). pii: e00850-19.
Open Access button

2019-08-09

Fig 2. Efficacy in the intention-to-treat population.

Fig 2. Efficacy in the intention-to-treat population.
  • Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F; IMblaze370 Investigators

  • Lancet Oncol. 2019 Jun;20(6):849-861.

2019-08-12

Fig 1. QC1 pH low insertion peptide (pHLIP) targets acidity at the surface of cancer cells and allows multi-spectral optoacoustic imaging.

Fig 1. QC1 pH low insertion peptide (pHLIP) targets acidity at the surface of cancer cells and allows multi-spectral optoacoustic imaging.
  • Roberts S, Strome A, Choi C, Andreou C, Kossatz S, Brand C, Williams T, Bradbury M, Kircher MF, Reshetnyak YK, Grimm J, Lewis JS, Reiner T

  • Sci Rep. 2019 Jun 12;9(1):8550.
Open Access button

2019-08-13

Fig. 3 TSGs are enriched among CLL-IPAs.

Fig. 3 TSGs are enriched among CLL-IPAs.
  • Lee SH, Singh I, Tisdale S, Abdel-Wahab O, Leslie CS, Mayr C

  • Nature. 2018 Sep;561(7721):127-131.

2019-08-14

Figure 1. Quantitative Proteomic Characterization of Cancer-Associated PP2A-Aα Mutations.

Figure 1. Quantitative Proteomic Characterization of Cancer-Associated PP2A-Aα Mutations.
  • Antao NV, Marcet-Ortega M, Cifani P, Kentsis A, Foley EA

  • iScience. 2019 Jul 17;19:74-82.
Open Access button

2019-08-15

Figure 4. Targeted T cell receptor (TCR) delivery and TCR‐like structures.

Figure 4. Targeted T cell receptor (TCR) delivery and TCR‐like structures.
  • Chandran SS, Klebanoff CA

  • Immunol Rev. 2019 Jul;290(1):127-147.
Open Access button

2019-08-16

Illustration of a PET image of a typical mCRPC patient with extensive [18F]FDHT-avid bone metastases reconstructed with a 100% count EARL1, b 50% count EARL1, c 100% count EARL2, and d 50% count EARL2.

Illustration of a PET image of a typical mCRPC patient with extensive [18F]FDHT-avid bone metastases reconstructed with a 100% count EARL1, b 50% count EARL1, c 100% count EARL2, and d 50% count EARL2.
  • Cysouw MCF, Kramer GM, Heijtel D, Schuit RC, Morris MJ, van den Eertwegh AJM, Voortman J, Hoekstra OS, Oprea-Lager DE, Boellaard R

  • EJNMMI Res. 2019 Jul 30;9(1):70.
Open Access button

2019-08-19

Fig. 2 Principal coordinates analysis (PCoA) plots of stool samples, labelled by necrotizing enterocolitis (NEC) status.

Fig. 2 Principal coordinates analysis (PCoA) plots of stool samples, labelled by necrotizing enterocolitis (NEC) status.
  • Romano-Keeler J, Shilts MH, Tovchigrechko A, Wang C, Brucker RM, Moore DJ, Fonnesbeck C, Meng S, Correa H, Lovvorn HN 3rd, Tang YW, Hooper L, Bordenstein SR, Das SR, Weitkamp JH

  • PLoS One. 2018 Oct 26;13(10):e0206366.
Open Access button

2019-08-20

Fig. 1. The repertoire of somatic mutations in primary SDC detected by the MSK-IMPACT assay.

Fig. 1. The repertoire of somatic mutations in primary SDC detected by the MSK-IMPACT assay.
  • Dogan S, Ng CKY, Xu B, Kumar R, Wang L, Edelweiss M, Scott SN, Zehir A, Drilon A, Morris LGT, Lee NY, Antonescu CR, Ho AL, Katabi N, Berger MF, Reis-Filho JS.

  • Hum Pathol. 2019 Apr 1. pii: S0046-8177(19)30049-8

2019-08-21

Obesity-induced alterations in periprostatic fat transcriptome are normalized by supplemental E2.

Obesity-induced alterations in periprostatic fat transcriptome are normalized by supplemental E2.
  • Bhardwaj P, Ikeda T, Zhou XK, Wang H, Zheng XE, Giri DD, Elemento O, Verma A, Miyazawa M, Mukherjee S, Falcone DJ, Wendel NK, Scherr DS, Dannenberg AJ

  • Carcinogenesis. 2019 Jul 20;40(7):914-923.
Open Access button

2019-08-22

Figure 1. Experimental Procedure for Generating and Screening Library of Secreted Bacterial Metabolites from Large-Scale Monocultures of SIHUMI Consortium Members.

Figure 1. Experimental Procedure for Generating and Screening Library of Secreted Bacterial Metabolites from Large-Scale Monocultures of SIHUMI Consortium Members.
  • Colosimo DA, Kohn JA, Luo PM, Piscotta FJ, Han SM, Pickard AJ, Rao A, Cross JR, Cohen LJ, Brady SF

  • Cell Host Microbe. 2019 Aug 14;26(2):273-282.e7.
Open Access button

2019-08-26

Fig 2. Forest plots of final OS overall population and all subgroup analyses.

Fig 2. Forest plots of final OS overall population and all subgroup analyses.
  • Robson ME, Tung N, Conte P, Im SA, Senkus E, Xu B, Masuda N, Delaloge S, Li W, Armstrong A, Wu W, Goessl C, Runswick S, Domchek SM

  • Ann Oncol. 2019 Apr 1;30(4):558-566.
Open Access button

2019-08-27

Figure 1. Baseline genomic alterations.

Figure 1. Baseline genomic alterations.
  • Mascarenhas J, Lu M, Kosiorek H, Virtgaym E, Xia L, Sandy L, Mesa R, Petersen B, Farnoud N, Najfeld V, Rampal R, Dueck A, Hoffman R

  • Blood. 2019 Aug 8;134(6):525-533.

2019-08-28

Differential methylation is driven by cell composition and cell type–specific changes.

Differential methylation is driven by cell composition and cell type–specific changes.
  • Park J, Guan Y, Sheng X, Gluck C, Seasock MJ, Hakimi AA, Qiu C, Pullman J, Verma A, Li H, Palmer M, Susztak K

  • JCI Insight. 2019 Jun 6;4(11). pii: 128886.
Open Access button

2019-08-29

Figure 1. Rescue of shRNA-Induced Self-Renewal Defects by Genetic Complementation.

Figure 1. Rescue of shRNA-Induced Self-Renewal Defects by Genetic Complementation.
  • Su J, Zhu D, Huo Z, Gingold JA, Ang YS, Tu J, Zhou R, Lin Y, Luo H, Yang H, Zhao R, Schaniel C, Moore KA, Lemischka IR, Lee DF

  • Cell Rep. 2019 Aug 6;28(6):1400-1409.e4.
Open Access button

2019-08-30

Figure 2. Cumulative incidence of (A) congestive heart failure and (B) myocardial infarction among childhood cancer survivors since original cancer diagnosis (years). From Mulrooney et al.

Figure 2. Cumulative incidence of (A) congestive heart failure and (B) myocardial infarction among childhood cancer survivors since original cancer diagnosis (years). From Mulrooney et al.
  • Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S, Bansal N, Ehrhardt MJ, Armenian SH, Scott JM, Hong B

  • Cardiovasc Res. 2019 Apr 15;115(5):922-934.
Open Access button

2019-09-03

Serum cytokines and CRP levels in subjects developing toxicities.

Serum cytokines and CRP levels in subjects developing toxicities.
  • Sauter CS, Senechal B, Rivière I, Ni A, Bernal Y, Wang X, Purdon T, Hall M, Singh AN, Szenes VZ, Yoo S, Dogan A, Wang Y, Moskowitz CH, Giralt S, Matasar MJ, Perales MA, Curran KJ, Park J, Sadelain M, Brentjens RJ

  • Blood. 2019 Aug 15;134(7):626-635.

2019-09-04

Fig. 2 Boxplot of follicular depth by anatomic site (n = 69).

Fig. 2 Boxplot of follicular depth by anatomic site (n = 69).
  • Connolly KL, Giordano C, Dusza S, Busam KJ, Nehal K

  • J Am Acad Dermatol. 2019 Feb;80(2):532-537.

2019-09-05

Figure 3. Clustering of 3D respiratory motion to different respiratory phases in a representative volunteer.

Figure 3. Clustering of 3D respiratory motion to different respiratory phases in a representative volunteer.
  • Liu J, Wang Y, Wen Z, Feng L, Lima APS, Mahadevan VS, Bolger A, Saloner D, Ordovas K

  • Sci Rep. 2019 Aug 9;9(1):11563.
Open Access button

2019-09-06

Fig. 1 Visit-based, systematic, self-reported assessments in the 1-2-3 Project.

Fig. 1 Visit-based, systematic, self-reported assessments in the 1-2-3 Project.
  • Desai AV, Klimek VM, Chow K, Epstein AS, Bernal C, Anderson K, Okpako M, Rawlins-Duell R, Kramer D, Romano D, Goldberg JI, Nelson JE

  • J Oncol Pract. 2018 Dec;14(12):e775-e785.

2019-09-09

Venogram of the chest under fluoroscopy demonstrating decreased blood flow in bilateral brachiocephalic and SVC due to thrombus (Red Arrows).

Venogram of the chest under fluoroscopy demonstrating decreased blood flow in bilateral brachiocephalic and SVC due to thrombus (Red Arrows).
  • Austin A, Al-Faris F, Modi A, Chopra A

  • Respir Med Case Rep. 2019 July 8; 28:100898.
Open Access button

2019-09-10

Fig 1. A summary of phase 3 trials for previously untreated advanced/metastatic NSCLC.

Fig 1. A summary of phase 3 trials for previously untreated advanced/metastatic NSCLC.
  • Peters S, Reck M, Smit EF, Mok T, Hellmann MD

  • Ann Oncol. 2019 Mar 26. pii: mdz109.
Open Access button

2019-09-11

Figure 1. Concept of the filigree pattern.

Figure 1. Concept of the filigree pattern.
  • Emoto K, Eguchi T, Tan KS, Takahashi Y, Aly RG, Rekhtman N, Travis WD, Adusumilli PS

  • J Thorac Oncol. 2019 Jul 25. pii: S1556-0864(19)30589-1.

2019-09-12

Fig. 1. Biopsy needle in an FDG-avid sternal lesion on PET-CT.

Fig. 1. Biopsy needle in an FDG-avid sternal lesion on PET-CT.
  • Kishore SA, Drabkin MJ, Sofocleous CT

  • PET Clin. 2019 Oct;14(4):427-436.

2019-09-13

Fig 1. Comparison between LIMORE and Primary Liver Cancers.

Fig 1. Comparison between LIMORE and Primary Liver Cancers.
  • Qiu Z, Li H, Zhang Z, Zhu Z, He S, Wang X, Wang P, Qin J, Zhuang L, Wang W, Xie F, Gu Y, Zou K, Li C, Li C, Wang C, Cen J, Chen X, Shu Y, Zhang Z, Sun L, Min L, Fu Y, Huang X, Lv H, Zhou H, Ji Y, Zhang Z, Meng Z, Shi X, Zhang H, Li Y, Hui L

  • Cancer Cell. 2019 Aug 12;36(2):179-193.e11.

2019-09-16

Fig 2. Considerations for planning preoperative radiation therapy to be delivered before extrapleural pneumonectomy for malignant pleural mesothelioma (the Surgery for Mesothelioma after Radiation Therapy technique).

Fig 2. Considerations for planning preoperative radiation therapy to be delivered before extrapleural pneumonectomy for malignant pleural mesothelioma (the Surgery for Mesothelioma after Radiation Therapy technique).
  • Gomez DR, Rimner A, Simone CB, Cho BCJ, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K

  • J Thorac Oncol. 2019 Jul;14(7):1172-1183.

2019-09-17

FH+/2SC+ immunophenotype: renal cell carcinoma; and cutaneous leiomyoma.

FH+/2SC+ immunophenotype: renal cell carcinoma; and cutaneous leiomyoma.
  • Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE.

  • Hum Pathol. 2019 Jul 9. pii: S0046-8177(19)30123-6.

2019-09-18

Figure 2. OncotypeDX score plotted against metabolomic Random Forest (RF) score.

Figure 2. OncotypeDX score plotted against metabolomic Random Forest (RF) score.
  • McCartney A, Vignoli A, Tenori L, Fornier M, Rossi L, Risi E, Luchinat C, Biganzoli L, Di Leo A

  • NPJ Breast Cancer. 2019 Aug 29;5:26.
Open Access button

2019-09-19

Fig. 1. Orthogonal planes of O‐MAR (left) and uncorrected CT reconstructions of the same patient.

Fig. 1. Orthogonal planes of O‐MAR (left) and uncorrected CT reconstructions of the same patient.
  • Sillanpaa J, Lovelock M, Mueller B

  • Med Dosim. 2019 Jul 30. pii: S0958-3947(19)30079-2.

2019-09-20

Fig 1. Anti-PD-1 before antigenic stimulation abrogates the antitumor effects of Vax + αPD-1.

Fig 1. Anti-PD-1 before antigenic stimulation abrogates the antitumor effects of Vax + αPD-1.
  • Verma v, Shrimali RK, Ahmad S, Dai W, Wang H, Lu S, Nandre R, Gaur P, Lopez J, Sade-Feldman M, Yizhak K, Bjorgaard SL, Flaherty KT, Wargo JA, Boland GM, Sullivan RJ, Getz G, Hammond SA, Tan M, Qi J, Wong P, Merghoub T, Wolchok J, Hacohen N, Janik JE, Mkrtichyan M, Gupta S, Khleif SN

  • Nat Immunol. 2019 Sep;20(9):1231-1243.

2019-09-23

Fig. 2 Base structural equation modeling path models.

Fig. 2 Base structural equation modeling path models.
  • Orom H, Schofield E, Kiviniemi MT, Waters EA, Biddle C, Chen X, Li Y, Kaphingst KA, Hay JL

  • Med Decis Making. 2018 Nov;38(8):1006-1017.

2019-09-24

Figure 1. Organization of the mouse gastrula stage embryo and regional specification of distinct cell types at the primitive streak.

Figure 1. Organization of the mouse gastrula stage embryo and regional specification of distinct cell types at the primitive streak.
  • Ferretti E, Hadjantonakis AK

  • Curr Opin Cell Biol. 2019 Aug 30;61:110-116.

2019-09-25

Albumin detection using free-standing nanosensor paint.

Albumin detection using free-standing nanosensor paint.
  • Budhathoki-Uprety J, Shah J, Korsen JA, Wayne AE, Galassi TV, Cohen JR, Harvey JD, Jena PV, Ramanathan LV, Jaimes EA, Heller DA

  • Nat Commun. 2019 Aug 9;10(1):3605.
Open Access button

2019-09-26

Figure 4. TGF-β Signaling Is Increased in Mir142−/− Type 1 ILCs.

Figure 4. TGF-β Signaling Is Increased in Mir142−/− Type 1 ILCs.
  • Berrien-Elliott MM1, Sun Y2, Neal C1, Ireland A1, Trissal MC1, Sullivan RP1, Wagner JA1, Leong JW1, Wong P1, Mah-Som AY3, Wong TN, Schappe T, Keppel CR, Cortez VS, Stamatiades EG, Li MO, Colonna M, Link DC, French AR, Cooper MA, Wang WL, Boldin MP, Reddy P, Fehniger TA

  • Immunity. 2019 Aug 2. pii: S1074-7613(19)30286-9.

2019-09-27

Fig 1. Flowchart of the pipeline of the voxel based approach.

Fig 1. Flowchart of the pipeline of the voxel based approach.
  • Palma G, Monti S, Thor M, Rimner A, Deasy JO, Cella L

  • Phys Med Biol. 2019 Aug 7;64(15):155006.

2019-09-30

Fig 1. Synthetic control groups derived from National Mesothelioma Registry.

Fig 1. Synthetic control groups derived from National Mesothelioma Registry.
  • Mansfield AS, Zauderer MG

  • Clin Cancer Res. 2019 Sep 15;25(18):5438-5440.

2019-10-01

Fig 1. A Pictorial Timeline of the Discovery of Herceptin.

Fig 1. A Pictorial Timeline of the Discovery of Herceptin.
  • Sawyers CL

  • Cell. 2019 Sep 19;179(1):8-12.